India therapeutic drug monitoring market is forecast to grow from an estimated $ 85 million in FY 2021 to $ 119 million by FY 2026 owing to the rising need of maintaining the drug levels in blood for prevention of diseases. Therapeutic drug monitoring is the practice of monitoring drug levels in the blood and maintaining them to an optimum level with the motive of preventing diseases, eradicating toxicity and many other health-related issues.
India therapeutic drug monitoring market has been gaining traction over years due to the increase in Indian population, especially the old age population. Precision medicines have been taking over normal medicines over the last few years, which has also led to the growth of the market. Furthermore, increasing government funding and novel product launches have fueled the market growth. However, scarcity of competent skillset is expected to hamper the market growth over the course of next five years.
India therapeutic drug monitoring market is segmented into product, technology, class of drug, end user, and region. The technology segment is further divided into immunoassays, chromatography-ms and others, out of which, immunoassays segment is expected to dominate the market in FY2021 as it is a precise method and gives more specific results compared to other technologies. Another driving factor of the segment is that it requires minimal maintenance and skills for operation.
The major players operating in India therapeutic drug monitoring market are Roche Diagnostics India Pvt Ltd, Abbott India Limited, bioM?rieux India, Bio-Rad laboratories India Pvt.Ltd, Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers India, Randox Laboratories (India) Private Limited, Sekisui Chemical India Private Limited, amongst others.
Years considered for this report:
- Historical Years: FY2016 - FY2019
- Base Year: FY2020
- Estimated Year: FY2021
- Forecast Period: FY2022 - FY2026
Objective of the Study:
- To analyze and estimate the market size of India therapeutic drug monitoring market from FY2016 to FY2019.
- To estimate and forecast the market size of India therapeutic drug monitoring market from FY2020 to FY2026.
- To classify and forecast India therapeutic drug monitoring market based on product, technology, class of drug, end user, region and company.
- To identify dominant region or segment in the India therapeutic drug monitoring market.
- To identify drivers and challenges for India therapeutic drug monitoring market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India therapeutic drug monitoring market.
- To conduct pricing analysis for India therapeutic drug monitoring market.
- To identify and analyze the profile of leading players operating in India therapeutic drug monitoring market.
- To identify key sustainable strategies adopted by market players in India therapeutic drug monitoring market.
Key Target Audience:
- End users, hospitals, laboratories and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to therapeutic drug monitoring
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, India therapeutic drug monitoring market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Consumables
- Equipment
- Immunoassays
- Chromatography-Ms
- Others
- Antiepileptic Drugs
- Antiarrhythmic Drugs
- Immunosuppressant Drugs
- Antibiotic Drugs
- Others
- Hospital
- Private Labs
- North
- East
- West
- South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in India therapeutic drug monitoring market.
US $
Euro €
GBP £
